Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: Data from the ESPOIR cohort
Annals of Rheumatic Diseases Oct 12, 2017
Roubille C, et al. - The 7-year tolerability profile of glucocorticoids (GC) for early rheumatoid arthritis (RA) is investigated in this study. The outcome revealed that the good safety profile of very low-dose GC for early active RA is supported by this 7-year analysis of the ESPOIR cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
